Saurabh Jain

Saurabh Jain is the executive chairman of Opyl, an ASX-listed clinical trial results analysis company that utilizes artificial intelligence to predict outcomes in medical trials. Under his leadership, Opyl has recently ventured into cryptocurrency investment, purchasing Bitcoin as part of a treasury strategy, which he views as an opportunity for better returns compared to traditional cash holdings.